A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Clinical trial NCT03227224 · COMPLETED
Trial details
- NCT number
- NCT03227224
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2019-01-12
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.